[1]
Warid AL-Laftah, F.A. et al. 2010. Pretreatment Clinical Variables Associated With the Response to Intravitreal Bevacisumab (Avastin) Injection In Patients With Persistent Diabetic Macular Edema. Journal of the Faculty of Medicine Baghdad. 52, 2 (Jul. 2010), 142–146. DOI:https://doi.org/10.32007/jfacmedbagdad.5221009.